Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1111/ocr.70004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Prevalence of Nasal Airway Obstruction in an Orthodontic Population Using the NOSE Scale Rebecca Petts Diana Ponsky Luciane Macedo de Menezes Tarek ElShebiny Kristina Wolf Juan Martin Palomo Orthodontics & Craniofacial Research ABSTRACT Introduction Nasal Airway Obstruction is a common problem affecting 30% of the general population and significantly impacts the quality of life. The objective of this research was to determine nasal airway obstruction prevalence in a population seeking orthodontic treatment using the Nasal Obstruction Symptom Evaluation ( NOSE) scale and to determine if practice modalities play a role. Methods The sample consisted of 431 patients seeking orthodontic care who completed the NOSE survey at an orthodontic residency program, a corporate practice, and a private practice. Results Obstruction was not correlated with age, gender, or trauma ( p < 0.05). The mean of all scores was 8.4 ± 14.7 (95% confidence interval [ CI] : 7.0–9.8), ranging from 0 to 80 on a scale of 100. The prevalence of nasal airway obstruction in the orthodontic population was: mild or above—43.9% (95% CI : 39.1%–48.7%); moderate or above—11.4% (95% CI : 8.6%–14.9%); severe—2.6% (95% CI : 1.3%–4.5%); and extreme—0.2% (95% CI : 0.0%–1.3%). The Kruskal–Wallis test showed no significant difference among patients at the three locations. Conclusions The Prevalence of Nasal Airway Obstruction (Mild to Extreme) in orthodontic populations was 43.9% (95% CI : 39.1%–48.7%), representing or slightly exceeding that of the general population. There was no significant difference between an orthodontic residency program, a corporate practice, and a private practice, indicating that the results are widely applicable. Orthodontists are encouraged to use the NOSE scale as a risk assessment tool, providing additional healthcare services to patients and potentially improving their quality of life. 10.1111/ocr.70004 http://onlinelibrary.wiley.com/termsAndConditions#vor